Malaria in Pregnancy Flashcards
(55 cards)
Malaria
• _______ of the world’s population is at risk
• 94% of cases and deaths occur in ______ Region
• ________ is one of the top five countries for malaria deaths
Half
Africa
Nigeria
the most important malaria health products: ________ , ________, ________ and ________.
ACTs
insecticides
LLINs
RDTs.
Malaria is caused by ________ parasites.
The parasites are spread to people through the bites of infected anopheles mosquitoes, called “malaria vectors”,
which bite mainly between _______ and _________.
Plasmodium parasites.
dusk ; dawn.
There are more than _____ different species of Anopheles mosquito and about _____ are malaria vectors of major
importance.
400 ; 30
The 4 species of the protozoan Plasmodium parasite
responsible for malaria in humans are Plasmodium __________ , Plasmodium __________, Plasmodium __________ and
Plasmodium __________.
Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae and
Plasmodium ovale.
Plasmodium __________ is the most deadly
falciparum
The intensity of transmission depends on factors related to
• the ————
• the _________
• the _________
• the _________
• the parasite
• the vector
• the human host
• the environment
Specific population risk groups
• Infants, children under _____ years
• ________ women
• People with __________
• __________ travelers from non-endemic areas
• Non-immune migrants
• Mobile populations
5 years ; Pregnant
HIV/AIDS ; International
Malaria in Pregnancy (MiP)
• Malarial infection during pregnancy is a major public health problem in _________ and _________ regions throughout the world.
tropical ; subtropical
The burden of malaria infection during
pregnancy is caused chiefly by _______________, the most common malaria species in Africa.
Plasmodium falciparum
Clinical features of MiP
• The incubation period of acute malaria is about ________
Symptoms
• Maybe asymptomatic
• Feeling of being unwell, fever, headaches, muscle/joint aches, poor appetite, nausea & vomiting.
• Ill looking, maybe anaemic, febrile, tachycardic, dehydrated.
• Parasite count _____%
10–15 days.
<2%
Clinical features of MiP
• Complicated malaria:
• impaired level of ________ , ___________
distress, ___________ , convulsions,
shock, abnormal bleeding, jaundice and
haemoglobinuria.
• Other laboratory findings- severe anaemia (Hb _____ g/dL), thrombo________, ____glycaemia,
acidosis (pH < _____ ), renal impairment.
• parasite count____%
consciousness ; respiratory distress,
pulmonary oedema
< 8 g/dL ; thrombocytopaenia
hypoglycaemia ; < 7.3
> 2%
Diagnosis of malaria
• Clinical or Laboratory
• Clinical- Symptoms
• Laboratory
• Microscopic (parasites- gold standard)- __________________
• Immunochromatographic (antigens derived from mp)- _____
• Molecular (parasite nucleic acids)- ______
• Serology (antibodies against mp- past exposure)- IFA/________
• Other investigations in patients with acute malaria should be determined by the severity of the infection and the
presence or otherwise of complications
Thick and thin blood film
RDTs ; PCR
ELISA
Differential diagnosis of MiP
• _________
• _________
• Hepatitis
• _________
• Meningitis
• _________
• Chorioamnionitis
• UTI
• Hepatitis
• HIV/AIDS
• Meningitis
• eclampsia
Complications of malaria in the
mother
• In areas of high and moderate (_________) malaria transmission, most adult women have developed enough immunity but during pregnancy, some of this acquired immunity becomes ________.
• __________ are most affected with the risk highest in the ____ and ______ trimesters.
• These infections maybe complicated by
acute __________→ _______ deficiencies,
anaemia, and if the patient suffers ante/post partum haemorrhage may go into _________→ death
stable ; lost.
Primigravidae
1st ; 2nd
haemolysis ; folate
shock
Complications of malaria in the
mother 2
- ________ malaria
- renal failure, coagulation failure
- Threatened and inevitable _______
- ___________ labour
- Associated systemic disturbances-
dehydration, electrolyte disturbances,
pulmonary oedema, hypoglycaemia
cerebral ; abortions
Premature
Complications of malaria on the
placenta & fetus
• The fetus is protected from malaria infection by certain mechanisms:
- passive immunity from ___________ passage of ___________________
- the ___________________ physically limits the passage of parasites into the foetal circulation
- the development of the malaria parasite is hindered in the presence of _______ haemoglobin
(_____)
transplacental
maternal malarial immunoglobin G antibodies
placental barrier
foetal haemoglobin
(HBF)
Effects on foetus contd
• Foetal effects are either sequel to the maternal complications or are due to a direct effect on the foetus
- _________
- foetal ______
- _______________
- intra-uterine ______
- rarely, _________ malaria
- prematurity
- foetal distress
- intra-uterine growth restriction
- intra-uterine death
- rarely, congenital malaria
NMEP
??
National malaria elimination program
Treatment of MiP
• Done in line with the _____ , _____ and _____ (3T) strategies (NMEP 2020)
• All suspected cases of malaria diagnosed using either Rapid
Diagnostic Test or microscopy
• All confirmed cases treated promptly with effective Artemisinin
combination therapy (ACT)
• All cases tracked through surveillance system
Test, Treat and Track
Antimalarial therapy
First trimester (uncomplicated)- ______
Second & third trimester- ______
Complicated malaria, regardless of trimester
Parenteral _________ or _________ till the patient is able to tolerate orally, then maintained on oral drugs
ACTs
ACTs
artesunate ; arthemeter
Prevention and control
Malaria prevention and control during
pregnancy has a three-pronged approach:
1. ________________________
2. _________________________
3. _________________________
Intermittent preventive treatment of malaria in pregnancy with Sulphadoxine and
Pyremethamine (IPTp-SP)
Long lasting insecticidal nets (LLINs)
Case management of malaria illness
IPTp-SP
• WHO recommends a schedule of at least _______ antenatal care visits during pregnancy and IPTp-SP should be delivered at ______ scheduled ANC
visit.
• Initially, _____ doses of IPTp-SP were given but this was updated in October, 2012 following an evidence review by WHO
eight ; each
2
IPTp-SP
Dosing should start in the ______ trimester and doses should be given atleast _______ apart with the objective of ensuring that atleast ____ doses are received
second
1month
3